Attached files
| file | filename |
|---|---|
| EX-32.1 - Glucose Health, Inc. | ex32-1.htm |
| EX-31.1 - Glucose Health, Inc. | ex31-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
Amendment No. 2
þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _____________ TO _____________
Commission File Number: 333-147917
Bio-Solutions Corp.
(Exact name of registrant as specified in its charter)
|
Nevada
|
98-0557171
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification
No.)
|
|
1250 NE Loop 410, Suite:200, San Antonio, TX 78209
|
|
(Address of principal executive offices) (Zip Code)
|
|
(210)268-9490
|
|
(Registrant’s telephone number, including area code)
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o No x
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated file, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer o
|
Accelerated filer o
|
|
Non-accelerated filer o (Do not check if a smaller reporting company)
|
Smaller reporting company x
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
|
Class
|
Outstanding at September 4, 2012
|
|
|
Common stock, $0.001 par value
|
67,190,397
|
EXPLANATORY NOTE
The purpose of this Amendment No. 2 to Bio-Solutions Corp. Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 13, 2012 (the “Form 10-Q”), is solely to correct the check mark to “yes” whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
This Amendment No. 2 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.
Item 6. Exhibits
See “Exhibit Index”.
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Bio-Solutions Corp.,
a Nevada corporation
|
|||
|
September 5, 2012
|
By:
|
/s/ William J Gallagher
|
|
|
William J Gallagher
Chief Executive Officer, Chief Financial Officer and a Director
(Principal Executive Officer and Financial and Accounting Officer)
|
EXHIBIT INDEX
|
EXHIBIT NO.
|
DESCRIPTION
|
|
31.1
|
Certification of Principal Executive/Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.
|
|
32.1
|
Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act
|